Wellgistics Health

Wellgistics Health Current Assets

Delisted·Sep 22, 2026

The Current Assets of Wellgistics Health (WGRX) as of Oct 27, 2026 is 1.68 M USD. In the previous year, Current Assets was 15.17 M USD — a change of -88.91% (lower).

Current Assets

1.68 MUSD

YoY

-88.91%

Last updated:

Current Assets of Wellgistics Health is 2025 1.68 M USD. Current Assets of Wellgistics Health was 2024 15.17 M USD. It decreases by -88.91% lower compared to the previous year.

The Wellgistics Health Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2022
0.00 USD
Jan 1, 2023
1,364.00 USD
Jan 1, 2024
15.17 M USD
Jan 1, 2025
1.68 M USD
The Wellgistics Health Current Assets history
YEARCurrent AssetsYoY
1.68 MUSD-88.91%
15.17 MUSD+1.11 M%
1,364.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wellgistics Health Stock analysis

What does Wellgistics Health do? Wellgistics Health Inc generates revenue through its technology platform DelivMeds, which connects clinical services to pharmacy operations and enables an end-to-end mobile application for patients to digitize their prescription journey. The company focuses on specialty medications like Kyzatrex, Semaglutide, and Tirzepatide, offering home delivery services to patients through its community-based model. Its primary customers include pharmacies, providers, pharmaceutical manufacturers, and payors seeking solutions for specialty medication management. The company's subsidiaries Wood Sage, LLC and Wellgistics LLC operate under the holding company structure, while Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC provide indirect support for its pharmacy hub services. DelivMeds serves as the central technology platform that facilitates prescription digitization, price transparency, and concierge services, directly targeting patients and healthcare stakeholders. The company's product portfolio includes Kyzatrex, Semaglutide, and Tirzepatide, which are specialty medications delivered via home delivery. Pharmacies, providers, manufacturers, and payors purchase the company's services to improve patient outcomes and streamline medication management processes. The community-based model emphasizes patient autonomy and clinical integration through the DelivMeds platform. Wellgistics Health Inc's revenue streams are derived from its subsidiaries' operations, with Wood Sage, LLC and Wellgistics LLC managing direct service delivery, while Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC support pharmacy hub functions. The company monetizes its technology platform by enabling end-to-end mobile solutions for prescription management, which enhances patient experience and operational efficiency for its clients. Specialty medication products like Kyzatrex, Semaglutide, and Tirzepatide are key revenue drivers through home delivery services. Wellgistics Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wellgistics Health stock

Current Assets of Wellgistics Health is 1.68 M USD in 2025.

Current Assets of Wellgistics Health changed from 15.17 M USD to 1.68 M USD, representing a -88.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Wellgistics Health since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Wellgistics Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Wellgistics Health

All Key Metrics — Wellgistics Health